Asia Pacific Cell Culture Market – Size, Outlook, Trends and Forecast (2024 – 2032)

Cell culture is the process where cells are grown in controlled conditions outside the environment. Cell culture refers to the removal of cells from an animal or plant and their subsequent growth in a favourable artificial environment. The cells may be removed from the tissue directly and disaggregated by enzymatic or mechanical means before cultivation, or they may be derived from a cell line or cell strain that has already been established.

Asia Pacific Cell Culture Market Size & Growth:

The Asia Pacific cell culture market was valued at $3.61 Billion in 2017 and is estimated to reach $7.81 Billion by 2024, at a CAGR of 12.4% during 2019-2025. The primary factors responsible for the Asia Pacific cell culture market growth are growing awareness about the benefits of cell culture-based vaccines, increasing demand for monoclonal antibodies, funding for cell-based research, growing preferences for single used technologies and launch of advanced cell culture products. Cell biology involves extensive research and development on new therapies such as stem cell and gene therapies. The reagents and equipment’s related to this research must be of the highest quality to provide accurate results. Due to the increasing need to maintain high-quality standards and fulfil with guidelines set up by regulatory bodies, the high cost of cell biology is hampering the market growth during the forecast period. Growing demand for 3d cell culture, increased risk of pandemics and communicable diseases and emerging markets are the significant Asia Pacific cell culture market opportunities during forecast 2019-2025

Asia Pacific Cell Cultures Market Segments Share:

The Asia Pacific cell culture market is segmented based on the product, application, and geography. By product, the Asia Pacific cell cultures market is segregated into equipment and consumables. Among the product segment, equipment segment shows the significant growth. By application, the market is categorised into biopharmaceutical, cancer research, stem cell technologies, drug screening & development and tissue engineering & regenerative medicine and others. Among these, cancer research is expected to register the highest growth in the Asia Pacific cell cultures market, and biopharmaceuticals hold the most significant market share during the forecast period. It is mainly due to cell cultured based vaccines, an increase in demand for monoclonal antibodies, growing preference for single-use technologies and launch of advanced cell cultured products. By end user, the market is classified into pharmaceuticals & biotechnology and research institutes. Among these, pharmaceuticals & biotechnology holds the most significant market share in Asia Pacific cell culture market and research institutes is expected to register the highest growth in Asia Pacific cell culture market due to growing awareness of cultured cell vaccines. By geography, Asia Pacific is segregated into China, India, South Korea, Australia & New Zealand. Among these, China holds the most significant market share in Asia Pacific cell culture market due to increase in demand for monoclonal antibodies and India is expected to register the highest growth in Asia Pacific cell culture market due to increase in funding of cell-based research and launch of advanced cell-based products.

Asia Pacific Cell Cultures Market Trends:

• July.2018: Danaher Corporation announced its intention to spin off its dental segment into independent publicly traded company Dental Co.
• January.2018: Cellgenix and Cevec cooperation lead to the result of the collaboration and license agreement for the development and GMP production.

Asia Pacific Cell Cultures Market Research Report:

An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.

To have a complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried out to understand the market more comprehensively.

Regional and Global Diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year

Identifying DROC in the current market and their impact on altering the market dynamics.

Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial analysis with significant competitors.

Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.

The primary critical players in the Asia Pacific Cell Cultures Market are:

• Merck KGaA
• Ge Healthcare
• Lonza Group AG
• Corning
• Becton, Dickinson and Company
• Thermo Fisher Scientific

Along with these companies, there were many other companies considered/ cited in the report while analysing the Asia Pacific cell cultures market. These companies hold substantial share-owning to the nature of the industry whereas the rest of the market shares are marginal chunks to regional and local level manufacturers. Other players have considerable presence owing to its robust brand image, geographical reach and stable customer base.